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Ca2+-dependent modulation via calmodulin, with consensus CaM-binding IQ motif playing a key role, has been documented
for most high-voltage-activated Ca2+ channels. The skeletal muscle Cav1.1 also exhibits Ca2+-/CaM-dependent modulation. Here,
whole-cellCa2+ current,Ca2+ transient,andmaximal,immobilization-resistantchargemovement(Qmax)recordingswereobtained
fromculturedmousemyotubes,totestaroleofIQmotifinfunctionofCav1.1.Theeﬀectofintroducingmutation(IQtoAA)ofIQ
motif into Cav1.1 was examined. In dysgenic myotubes expressing YFP-Cav1.1AA,n e i t h e rC a 2+ currents nor evoked Ca2+ transients
were detectable. The loss of Ca2+ current and excitation-contraction coupling did not appear to be a consequence of defective
traﬃcking to the sarcolemma. The Qmax in dysgenic myotubes expressing YFP-Cav1.1AA was similar to that of normal myotubes.
These ﬁndings suggest that the IQ motif of the Cav1.1 may be an unrecognized site of structural and functional coupling between
DHPR and RyR.
1.Introduction
Calcium entering the cell through voltage-gated Ca2+ chan-
nels plays an important role in mediating a wide variety of
cellular events and includes feedback processes that regulate
activity of the channel itself. The Ca2+-dependent mod-
ulation of channel activity mediated by the Ca2+-binding
p r o t e i nc a l m o d u l i n( C a M )i sf o u n di nm a n yi o nc h a n n e l s
including the Cav1f a m i l y[ 1]. Ca2+-dependent inactivation
(CDI) of Cav1.2 is mediated by CaM, and its structural
determinants have been assigned to the proximal region of
the C-terminus of Cav1.2 [1, 2]. Three domains have been
identiﬁed within this region: a Ca2+ binding EF-hand motif,
a CaM-tethering site, and a CaM-binding IQ motif. The EF-
hand motif, located ∼16 residues beyond the end of the last
transmembrane segment (IVS6), is absolutely necessary for
CDI. The CaM-tethering site, which consists of both preIQ3
and IQ motifs, resides 50 amino acids downstream from the
EF-hand motif and binds Ca2+-free CaM (apo-CaM) at rest-
ing [Ca2+]i. The IQ motif resides downstream from the EF-
hand motif and the pre-IQ3 domain, and it binds Ca2+-CaM.
When the interaction of CaM with either of these domains is
compromised, CDI is reduced or eliminated [1, 2].
Recently, it has been demonstrated that the skeletal
muscle L-type Ca2+ channel (Cav1.1) also displays CDI
mediated by CaM and that CaM associates with Cav1.1 in
vivo [3]. The initial 200 amino acids of the C-terminus
of the Cav1.1 are highly conserved and contain the above-
described domains including the IQ motif. CaM binding
t ot h eI Qm o t i fo fC a v1.2 channel has been shown to be
necessaryforCDI,andthemutationoftheisoleucine(I1624)
and glutamine (Q1625) to alanines (AA) in the IQ motif of
Cav1.2 resulted in ablation of CDI and signiﬁcant reduction
of apoCaM binding to Cav1.2 [1, 2, 4]. Whether the IQ motif
in Cav1.1 plays a similar role remains to be determined.
In the present work, myotubes cultured from normal
and dysgenic (lacking endogenous Cav1.1) mice were used
to investigate the role of the IQ motif in the function of
Cav1.1. The results presented demonstrate that the IQ motif
in the C-terminus of Cav1.1 is critical for function of Cav1.1
as a voltage sensor as well as Ca2+ channel. Furthermore,
the results indicate that the IQ motif may be a previously
unrecognized site of protein-protein interaction between
Cav1.1 and the skeletal muscle ryanodine receptor (RyR1)
and may play a role in skeletal muscle excitation-contraction
(EC) coupling.2 Journal of Biomedicine and Biotechnology
2.ExperimentalProcedures
2.1. Molecular Biology. The coding sequence of yellow ﬂuo-
rescent protein- (YFP-) tagged Cav1.1 channel (YFP-Cav1.1)
was a gift from Dr. K. Beam and is described in detail
elsewhere [5]. The residues isoleucine (I) and glutamine (Q)
at codons 1529-1530 of rabbit Cav1.1 [6]w e r es u b s t i t u t e d
with alanine (A) using the QuikChange II mutagenesis
kit (Stratagene, La Jolla, CA), using the YFP-Cav1.1 as
a template. The construct YFP-Cav1.1AA was veriﬁed by
restriction digest analysis and sequencing.
2.2. Cell Cultures. Primary myotubes were cultured from
normal or dysgenic newborn mouse skeletal muscle as
previously described [3]. For confocal microscopy purposes,
primary cultures of myotubes were plated onto 35mm
culture dishes with integral no. 0 glass coverslip bottoms
(MatTek) instead of Primaria dishes. Approximately one
week after plating, dysgenic myotubes were injected with
expression plasmids (cDNAs) encoding either YFP-Cav1.1 or
YFP-Cav1.1AA at concentrations of 0.2μg/μL, respectively. In
experiments assessing the eﬀects of CaM on Ca2+ transients,
normal myotubes (∼o n ew e e ki nc u l t u r e )w e r ei n j e c t e d
with expression plasmids encoding CaMwt or CaM1234 (gift
of Dr. Yue) and green ﬂuorescent protein (pEGFP-C1, BD
Biosciences Clontech, CA) at concentrations of 0.1 and
0.02μg/μL, respectively. Successfully transfected myotubes
were identiﬁed 36–48 hours after injection by their yellow or
green ﬂuorescence under UV illumination.
2.3. Electrophysiology. Patch pipettes were constructed of
borosilicate glass and had resistances of 1.8–2.5 MΩ when
ﬁlled with the standard internal solution, which contained
(in mM) 145 Cs-aspartate, 10 Cs2-EGTA, 5 MgCl2,a n d1 0
HEPES (pH 7.4 with CsOH). The external solution con-
tained (in mM) 145 tetraethylammonium chloride (TEA-
Cl), 10 CaCl2, 0.003 tetrodotoxin, and 10 HEPES (pH 7.4
with TEA-OH). The holding potential was –80mV, and
test pulses were preceded by a 1-s prepulse to –30mV
to inactivate endogenous T-type Ca2+ currents. Recorded
membrane currents were corrected oﬀ line for linear com-
ponents of leakage and capacitance by digitally scaling and
subtracting the average of 10 preceding control currents,
elicited by hyperpolarizing voltage steps (30mV amplitude)
from –50mV. Ca2+ currents were normalized by linear
cell capacitance (expressed in pA/pF). Values for Gmax, the
maximal Ca2+ conductance, were obtained by ﬁtting the
measured currents according to the following equation:
Ipeak =
Gmax (V − VR)

1+e x p[−(V −V1/2)/k]
,( 1 )
where Ipeak is the peak current activated at the test potential
V,VR is theextrapolatedreversalpotential, V1/2 is thepoten-
tialforhalf-maximalactivationoftheCa2+ conductance,and
k is a slope factor.
Thefractionofcurrentremainingattheendofan800ms
test pulse (r800) was determined by dividing the current
remaining at the end of test pulse by the peak current, and
this ratio was used to quantify the level of inactivation
r800 =
Iend
Ipeak
. (2)
For measurements of charge movement, 0.5mM Cd2+
and 0.1mM La3+ were added to the external solution to
block Ca2+ currents. Charge movements were elicited in
response to a prepulse protocol that consisted of a 1-s
prepulse to −30mV and a subsequent 40ms repolarization
to a pedestal potential (−50mV), followed by a 25ms
depolarization to +40mV. The maximum amount of charge
that can be moved (Qmax) was obtained by integrating the
c h a r g em o v e m e n tc u r r e n ta tt e s tp o t e n t i a lo f+ 4 0m V .L i n e a r
leak and capacity currents were subtracted on line using
−P/4 delivered from the holding potential (−80mV) before
each pulse. Charge movements were normalized to total cell
capacitance (nC/μF).
To measure relative changes in voltage-gated Ca2+ release
from the SR, the Ca2+ indicator K5-Fluo-3 (0.5mM) (Molec-
ular Probes) was included in the pipette solution. After
rupture of the cell membrane and entry into the whole
cell conﬁguration, cells were allowed to dialyze for about
5min before recording in order to achieve adequate loading
with indicator dye. Fluorescent emission was measured
by a photomultiplier system (Biomedical Instrumentation
Group, University of Pennsylvania). The set of ﬁlters used
to record the ﬂuorescent signal from Fluo-3 was as follows:
excitation band-pass ﬁlter of 470/20nm; dichroic long-pass
mirror (510nm); emission long-pass ﬁlter of 520nm. After
rupture and dye loading into the cell, the baseline ﬂuo-
rescence (Fbase) was monitored. The increase in ﬂuorescent
signal during depolarization was expressed as ΔF/F,w h e r e
ΔF represents the increase in ﬂuorescence above baseline
ﬂuorescence (ΔF = Ftransient − Fbase), and F is Fbase.P e a k
ﬂuorescence during each test pulse was plotted as a function
of test potential V and ﬁtted according to the following
equation:
ΔF
F
=
(ΔF/F)max 
1+e x p [(VF1/2 − V)/kF]
,( 3 )
where (ΔF/F)max is the maximal ﬂuorescent change, VF1/2
is the potential for half-maximal activation of the Ca2+
transient, and kF is a slope factor.
All recordings were performed at room temperature
(∼20◦C), and data are reported as mean ± SEM; n indicates
the number of myotubes tested. Data sets were statistically
compared by an unpaired, two-sample Student’s t-test, with
a conﬁdence interval of at least 95%.
2.4. Confocal Microscopy. Cells were bathed in rodent ringer
(in mM: 146NaCl, 5KCl, 2CaCl2,1 M g C l 2, 11 glucose,
10HEPES; pH 7.4 adjusted with NaOH) and examined
with an LSM 510 META laser scanning microscope (Zeiss,
Thornwood, New York) with 40X oil immersion objective.
The laser line (514nm) of the argon laser (30mW maximum
output, operated at 50% or 6.3A) was used to excite YFPJournal of Biomedicine and Biotechnology 3
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Figure 1: Ca2+-binding ability of CaM does not aﬀect skeletal muscle EC coupling. (a) The average peak current density (Ipeak)i sp l o t t e d
as a function of membrane potential (Vtest). Data were obtained from the indicated number of myotubes for each group. The smooth lines
through the data were generated by using equation (1) (see Methods) and the average values. (b) The average peak ﬂuorescence (ΔF/F)i s
plotted as a function of membrane potential (Vtest). Data were obtained from the indicated number of myotubes for each group. The smooth
lines through data represent Boltzmann ﬁts to the average data using equation (3) (see Methods).
ﬂuorophore. Emissions of YFP were recorded in single-track
conﬁguration with a long-pass ﬁlter of 530nm (Chroma,
Rockingham, Vermont). Fluorescence signals were analyzed
by the 510 LSM Image Examiner software (Zeiss, Thorn-
wood, New York).
2.5. Immunocytochemistry. P r i m a r yc e l lc u l t u r e sw e r ep l a t e d
onto 35mm culture dishes with integral no. 0 glass coverslip
bottoms(MatTek).MyotubesexpressingconstructsofCav1.1
were identiﬁed by ﬂuorescence. The cultures will be ﬁxed
with 100% methanol at −20◦C for a minimum of 20min.
Cells were then incubated for 1 hour in PBS (phosphate-
buﬀered saline) containing 1% BSA (bovine serum albumin)
and 10% goat serum to block unspeciﬁc labeling. After 3
washes with PBS/BSA (.2%), cell cultures were incubated
withspeciﬁcprimaryantibodyagainsttheRyR1(34C,Devel-
opmental Studies Hybridoma Bank (DSHB), UI) (dilution
1:4000) overnight at 4◦C. Cells were washed out 3 times
with PBS/BSA (.2%), followed by 1 hour of incubation
with secondary antibody conjugated with Alexa 568 (at ﬁnal
dilution 1:5,000, goat anti-rabbit IgG, Invitrogen). Cells
were then washed 3 times with PBS/BSA (.2%) to remove
unbind secondary antibody and assessed with a confocal
microscope.
3. Results
Ca2+-binding ability of CaM does not aﬀect skeletal muscle EC
coupling. First, I addressed the question whether the Ca2+-
binding ability of CaM plays any role in skeletal muscle
EC coupling. Overexpressed mutant CaM which does not
bind Ca2+ (CaM1234) can displace approximately 70% of
endogenous CaM, as reﬂected by abolishment of CDI of
Cav1.1 [3]. However, overexpression of either CaMwt or
CaM1234 in normal myotubes did not signiﬁcantly aﬀect
either current-voltage (I/V) relationship (Figure 1(a))o r
voltage-gated Ca2+ release from SR as indicated by similar
peak ﬂuorescence-voltage relationship (ΔF/F-V)i nc o m p a r -
ison with uninjected normal myotubes (Figure 1(b)). This
result suggests that either the Ca2+-binding ability of CaM
or CaM itself does not play a role in skeletal muscle EC
coupling. However, CaM associates with Cav1.1 in vivo [3]
andthatindicatesthepossibilitythatCaMmaystillserveasa
structural subunit of Cav1.1, that is, that interaction between
CaM and Cav1.1 can stabilize the DHPR complex. By doing
so, it may also ensure proper structural and functional
coupling between DHPR and RyR1.
Therefore, I examined whether CaM association with
Cav1.1 is necessary for its function as a voltage sensor for
E Cc o u p l i n g .T h eI Qm o t i fo fC a v1.1 has been shown to
bind CaM similar to IQ motifs of Cav1.3 and Cav2 channels
[7]. Introduction of the mutation IQ/AA in the IQ motif
of the cardiac L-type Ca2+ channel (Cav1.2) resulted in
abolishment of CDI and signiﬁcant reduction of apoCaM
binding to Cav1.2 [2, 4]. Thus, corresponding IQ motif
mutation in the C-terminus of Cav1.1 was obvious place to
start.
Themutation(IQ/AA)intheCaM-bindingsiteofCav1.1
disables function of Cav1.1 as a Ca2+ channel and voltage
sensor for EC coupling. I introduced the IQ/AA mutation
in the C-terminus of Cav1.1 and investigated how this4 Journal of Biomedicine and Biotechnology
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Figure 2: The IQ/AA mutation disables function of Cav1.1 as a Ca2+ channel and voltage sensor for EC coupling. Representative whole-cell
L-type Ca2+ currents recorded from dysgenic myotubes expressing either (a) YFP-Cav1.1 (cell 1 (05-10-02); linear capacitance C = 587 pF)
or (b) YFP-Cav1.1AA (cell 1 (01-13-03); linear capacitance C = 201 pF). Note that the current scales are diﬀerent in (a) and (b). (c) The
average peak current density (Ipeak) is plotted as a function of membrane potential (Vtest). Data were obtained from the indicated number of
myotubes for each group. The smooth lines through the data were generated by using equation (1) (see Methods) and the average values. (d)
The average peak ﬂuorescence (ΔF/F) is plotted as a function of membrane potential (Vtest). Data were obtained from the indicated number
of myotubes for each group. The smooth lines through data represent Boltzmann ﬁts to the average data using equation (3) (see Methods).
mutation will alter Cav1.1 function as Ca2+ channel and
voltagesensorforEC coupling.Introductionofthemutation
IQ/AA in the IQ motif of Cav1.2 resulted in abolishment
of CDI and signiﬁcant reduction of apoCaM binding to
Cav1.2 [2, 4]. Whether IQ motif in the Cav1.1 plays a similar
role is unknown. Dysgenic myotubes expressing either YFP-
Cav1.1 or YFP-Cav1.1AA were used to examine the role of
IQ motif in Ca2+-dependent inactivation (CDI) of Cav1.1.
Injections of plasmids encoding various constructs of Cav1.1
into dysgenic myotubes at concentrations of 0.2–0.5 μg/μL
have been previously demonstrated to produce a similar
extent of maximal, immobilization-resistant charge move-
mentandsimilarCa2+ currentdensitiesasnormalmyotubes,
which corresponds to similar protein expression levels
[3, 6, 8–10].
Figure 2(a)shows Ca2+ currentsmediated byYFP-Cav1.1
expressed in dysgenic myotube. The fraction of current
remaining at the end of the pulse (r800) displayed a U-
shaped voltage dependence (data not shown), consistent
with a current-dependent inactivation process. In such a
process, the extent of inactivation varies in proportion with
the amplitude of the inward calcium current, which in
turn depends on the number of conducting channels and
the electrochemical driving force on calcium. Inactivation
was minimal at a test potential of +10mV, as reﬂected
by an r800 value of 0.9 ± 0.08 (n = 7), and maximal
at a test potential of +40mV, as reﬂected by a minimum
r800 value of 0.74 ± 0.03 (n = 7). Correspondingly, the
Ca2+ current attained its maximum conductance at +40mV
(Figure 1(c)). Thus, Ca2+ currents mediated by YFP-Cav1.1Journal of Biomedicine and Biotechnology 5
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Figure 3: YFP-Cav1.1AA displays similar expression pattern as YFP-Cav1.1 in dysgenic myotubes. Confocal images of either YFP-Cav1.1 (a)
or YFP-Cav1.1AA (b) yellow ﬂuorescence in dysgenic myotubes. Bar 50μm.
displayed a current-dependent inactivation process, current-
voltage (I-V) relationship (Figure 2(c)), and maximal Ca2+
ion conductance (Gmax = 166 ± 18 nS/nF; n = 7) similar
to the endogenous Cav1 . 1o fn o r m a lm y o t u b e s[ 3]. These
results suggest that YFP fused to the N-terminus of Cav1.1
does not interfere with channel function.
In contrast, dysgenic myotubes expressing YFP-Cav1.1AA
(Figures 2(b) and 2(c)) displayed either very small (<1pA/
pF) or no measurable Ca2+ currents. This is a very dramatic
and surprising result considering that the corresponding
mutation (IQ/AA) in the IQ motif of Cav1.2 resulted only
in ablation of CDI but did not aﬀect the I-V relationship
of Ca2+ currents mediated by Cav1.2 [2]. Further voltage-
gated Ca2+ currents and SR Ca2+ release were measured
simultaneously from dysgenic myotubes expressing YFP-
Cav1.1AA and compared with recordings from uninjected
normal myotubes and normal myotubes overexpressing
CaMwt or CaM1234. The voltage-gated Ca2+ release from SR
was completely abolished in dysgenic myotubes expressing
YFP-Cav1.1AA (Figure 2(d)).
The loss of Cav1.1AA function could be a result of
several scenarios such as that mutation caused misfolding
of protein and insuﬃcient membrane targeting or that
protein-protein interaction between RyR1 and Cav1.1 was
signiﬁcantly disturbed. If the latter possibility is the case, this
result suggests that either the IQ motif itself or association
of CaM with Cav1.1 is necessary for orthograde signaling
from Cav1.1 to RyR1, which underlies skeletal muscle EC
coupling.
The IQ/AA mutation does not prevent proper targeting of
Cav1.1 into sarcolemma. T h es e v e r el o s so ff u n c t i o n ,a b o l -
ished Ca2+ current and orthograde signaling mediated by the
Cav1.1AA, could be explained by compromised targeting of
Cav1.1 to the T-SR junction as a result of incomplete protein
folding.
Figure 3 shows confocal images of yellow ﬂuorescence
from a dysgenic myotube expressing either YFP-Cav1.1
or YFP-Cav1.1AA. Expression of YFP-Cav1.1 (a) or YFP-
Cav1.1AA (b) resulted in the appearance of small yellow
ﬂuorescence puncta located near the cell surface. The small
puncta correspond to groups of Cav1.1 localized to T-SR
junctions; these puncta are similar in size and distribution to
thoseofCav1.1focirevealedbyimmunohistochemistry[11].
There is a similar staining of the membrane and distribution
of puncta in both myotubes, suggesting that both constructs
are likely targeted to T-SR junctions.
ToconﬁrmtargetingofYFP-Cav1.1AA tothesarcolemma,
the Qmax was measured at +40mV (Figure 4). The Qmax in
dysgenicmyotubesexpressingCav1.1AA (5.9±0.5nC/μF;n =
2 7 )w a ss i m i l a rt ot h a to fn o r m a lm y o t u b e s( 5 .5±0.4 nC/μF;
n = 16), but signiﬁcantly larger (P<0.001) than in dysgenic
myotubes alone (2.5 ± 0.2nC/μF; n = 18). This ﬁnding
suggests that IQ/AA mutation in Cav1.1 did not prevent the
protein from being properly targeted or undergoing voltage-
dependent conformational changes, which strongly suggest
proper folding as intramembrane segment S4 of Cav1.1 is
responsible for voltage-dependent movement.
To further conﬁrm Cav1.1AA proper targeting into T-SR
junctions and site of EC coupling, I investigated colocal-
ization of Cav1.1 and RyR1. Dysgenic myotubes expressing
either YFP-Cav1.1 or YFP-Cav1.1AA (yellow ﬂuorescence:
YFP was artiﬁcially assigned as green) were incubated with
speciﬁc primary antibody against the RyR1 followed by
incubation with secondary antibody conjugated with Alexa
568 (red ﬂuorescence). Colocalization of green and red
ﬂuorescence results in yellow pattern suggests colocalization
of YFP-Cav1.1 and RyR1 in T-SR junctions in vivo (see
Figures 5(g) and 5(h)). Colocalization patterns of YFP-
Cav1.1AA withRyR1werecomparedtoYFP-Cav1.1andRyR1
patterns in 5 diﬀerent experiments. Colocalization patterns
of either YFP-Cav1.1 or YFP-Cav1.1AA with RyR1 were
similar and have been analyzed by MetaMorph 7 software
(Molecular Devices). Colocalization in near surface slices of
z-stacks of YFP-Cav1.1 and RyR1 was 83 ± 4% (n = 7),
and colocalization of YFP-Cav1.1AA and RyR1 was 85 ± 2%
(n = 7). These results strongly suggest that YFP-Cav1.1AA is
targeted into T-SR junctions.
Together these results suggest that the IQ/AA mutation
is not likely to aﬀect protein folding within membrane.
Furthermore, much more drastic alternation or deletions6 Journal of Biomedicine and Biotechnology
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Figure 4: Cav1.1AA generates normal densities of intramembrane
charge movement. The average maximal, immobilization-resistant
charge movement at +40 mV (Qmax) obtained from the indicated
number of myotubes for each group. The charge movements
were elicited by 25 ms depolarizations from a pedestal potential
(−50mV) to +40 mV. Symbols and error bars represent mean ±
SEM.
in Cav1.1 sequence did not have such dramatic eﬀects [12,
13].
Taking altogether, the loss of both ionic Ca2+ current and
skeletal muscle EC coupling in Cav1.1AA along with charge
movement similar to normal myotubes suggests that the IQ
m o t i fo ft h eC a v1.1 may be unrecognized site of protein-
protein interaction between Cav1.1 and RyR1 and play a role
in both orthograde and retrograde signaling.
4. Discussion
The present study provides new information about the
skeletal muscle L-type Ca2+ channel (Cav1.1). Speciﬁcally,
the data demonstrate in vivo that the IQ motif in the C-
terminus of Cav1.1 is critical for function of Cav1.1 as a
voltage sensor as well as a Ca2+ channel. Furthermore, the
results indicate that the IQ motif, in addition to II-III loop,
may be a previously unrecognized site of protein-protein
interaction between Cav1.1 and RyR1 and, thus, may play a
role in skeletal muscle EC coupling.
Cav1.1 is localized in regions of the T-tubular membrane
that are closely apposed to the sarcoplasmic reticulum (i.e.,
the T-SR junction), and the primary role of Cav1.1 is to serve
as the voltage sensor for skeletal muscle EC coupling. The
second protein that plays a major role in this process is the
skeletal muscle ryanodine receptor (RyR1). RyR1 is localized
in junctional SR membrane and functions as calcium release
channel. The mechanism of signal transmission between
Cav1.1 and RyR1 is still incompletely understood, but the
mostacceptedviewisthattheyaremechanicallycoupledand
interact with each other through protein-protein interaction
(orthograde and retrograde signaling). Orthograde signaling
is the signal from Cav1 . 1t oR y R 1 ,i nw h i c hm o v e m e n t
of the voltage sensors in Cav1.1 trigger opening of RyR1
and release of Ca2+ from the SR (EC coupling). Retrograde
signaling is communication from RyR1 to Cav1.1, in which
RyR1 somehow increases the amount of L-type Ca2+ current
mediated by Cav1.1 [8, 9].
The Ca2+ conductance of Cav1.1 channel is not necessary
forfunctionalexcitation-contractioncouplingbetweenRyR1
and Cav1.1; however, a direct protein-protein interaction
between these two proteins in multiple sites is. It has been
shown that cytoplasmic loops of Cav1.1 and several regions
of RyR1 play important role for normal physiological EC
coupling in skeletal muscle [10, 14–17]. It has been also
shown that protein-protein interaction between RyR1 and
Cav1.1 is necessary for Cav1.1 display of Ca2+ conductance
(retrograde signaling) [8]. It is clear that there are multiple
contact sites between RyR1 and Cav1.1 and not all of them
are recognized and understood, yet. The most investigated
region of contact between RyR1 and Cav1.1 in Cav1.1 is
II-III cytoplasmic loop, but other regions play a role [14,
15].
In the present experiments, normal myotubes and
dysgenic myotubes expressing either YFP-Cav1.1 or YFP-
Cav1.1AA were used to examine the role of the IQ motif in
both functions of Cav1.1, as a voltage sensor in EC coupling
and Ca2+ channel. The primary cultures of skeletal muscle
myotubes provide a natural cellular environment for Cav1.1.
First, I examined whether a fusion of YFP to Cav1.1 would
interfere with its function. The Ca2+ currents mediated by
YFP-Cav1.1 displayed an I-V relationship similar to the
endogenous Cav1.1 [3], suggesting that YFP fused on the N-
terminus of Cav1.1 does not interfere with its channel func-
tion, as was also shown by others [5]. Endogenous Cav1.1
also exhibits CaM-mediated Ca2+-dependent inactivation
(CDI) [3]. The Ca2+ currents mediated by YFP-Cav1.1 also
displayed current-dependent inactivation similar to the CDI
of endogenous Cav1.1, further supporting observation that
fusion of YFP with Cav1.1 does not interfere with channel
function.
Second, I examined how IQ/AA mutation in Cav1.1 will
aﬀect its function. Surprisingly, the intriguing ﬁnding of
the present study was that dysgenic myotubes expressing
YFP-Cav1.1AA displayed either very small or no measurable
Ca2+ currents. Signiﬁcant decrease or abolishment of Ca2+
current through Cav1.1 could have resulted from improper
targeting or folding of the protein. If Cav1.1AA was retained
inside of myotubes due to incorrect folding and targeting,
neither Ca2+ currents nor Qmax would be obtained. The
absence of Ca2+ currents in some of the dysgenic myotubes
expressing YFP-Cav1.1AA would suggest both. However,
even though the Ca2+ current was absent, Qmax comparable
with normal myotubes was observed. The Qmax measured
in dysgenic myotubes expressing Cav1.1AA was signiﬁcantly
larger (P<0.001) than in dysgenic myotubes alone, but
similar to that of normal myotubes measured here andJournal of Biomedicine and Biotechnology 7
(a) (b) (c)
(d) (e) (f)
(g) (h)
Figure 5: Cav1.1AA is targeted to T-SR junctions. Confocal images of colocalization of either YFP-Cav1.1 (a) or YFP-Cav1.1<?erm?>AA<?erm?>
(b) green ﬂuorescence and immunolabeled RyR1 ((d) and (e)) red ﬂuorescence in dysgenic myotubes. (g) and (h) represent overlay of (a)
and (d), and (b) and (e), respectively. The control dysgenic myotube (no Cav1.1) immunolabeled without (c) and with (f) primary Ab(34C).
Bar, 20μm.
to the Qmax measured in dysgenic myotubes expressing
various constructs of wt Cav1.1 at the similar experimental
conditions elsewhere [6, 7].
The amount of Qmax in dysgenic myotubes expressing
YFP-Cav1.1AA suggests that IQ/AA mutation in Cav1.1 did
not prevent the protein from being properly targeted and
that protein can undergo voltage-dependent conformational
changes. The size of small measurable Ca2+ currents mea-
sured in some (6 out of 14) of the dysgenic myotubes
expressing Cav1.1AA (<1pA/pF) was similar to L-type Ca2+
currents measured in dyspedic (lacking a functional gene of
RyR1) myotubes [7], suggesting a loss of retrograde signaling
from RyR1. Endogenous Cav1.1 channels are present in
sarcolemma of the dyspedic myotubes in similar density as
in normal myotubes, as was demonstrated by comparable
Qmax (dyspedic: 4.0 ± 1.4 nC/μF; normal: 6.4 ±2.8 nC/μF)
[7]. Thus, the amount of Qmax measured in dysgenic
myotubes expressing Cav1.1AA (5.9 ± 0.5 nC/μF) is in8 Journal of Biomedicine and Biotechnology
good agreement with the previously published values, and
indicates that the IQ/AA mutation may have also disrupted
retrograde signaling between Cav1.1 and RyR1. The similar
expression patterns and comparable colocalization of YFP-
Cav1.1 and YFP-Cav1.1AA with RyR1 in dysgenic myotubes
obtainedbyconfocalmicroscopyandimmunocytochemistry
further support the argument that YFP-Cav1.1AA seems to
be folded and targeted properly to the T-SR junctions. In
addition, much more drastic alternation or deletions in
Cav1.1 sequence did not have such dramatic eﬀects [12, 13].
Third, the IQ/AA mutation in C-terminus of Cav1.1 had
ad r a m a t i ce ﬀect on its function as a voltage sensor for EC
coupling.EventhoughamountofQmax indysgenicmyotubes
expressingYFP-Cav1.1AA issuﬃcienttosupportECcoupling
(see above), the voltage-gated Ca2+ release from SR was
completely abolished in these cells. This ﬁnding suggests that
either tethering of CaM to Cav1.1 as a structural subunit
or the IQ motif itself is necessary for orthograde signaling
between Cav1.1 and RyR1 (EC coupling). Overexpression
of CaMwt and CaM1234 in normal myotubes did not sig-
niﬁcantly aﬀect the peak ﬂuorescence-voltage relationship
(ΔF/F-V) in comparison with uninjected normal myotubes,
suggesting that the Ca2+-binding ability of CaM does not
play a role in skeletal muscle EC coupling in single twitch
contractions.
For the ﬁrst time, the present study shows that the IQ
motif plays a role in both orthograde (skeletal muscle EC
coupling) and retrograde (Ca2+ current) signaling between
Cav1.1andRyR1invivo.SeveralregionsofRyR1wereshown
to participate in protein-protein interactions between Cav1.1
and RyR1. However, until recently only the II-III loop of the
Cav1.1hasbeenthoughttobenecessarytoconveyorthograde
and retrograde signaling between Cav1.1 and RyR1. The
present ﬁndings suggest that the C-terminus in addition
to the II-III loop participates in and is necessary for the
correct transmission of signals between Cav1.1 and RyR1.
These results support previously published in vivo ﬁndings
that in addition to the II-III loop of Cav1.1 additional
intracellular loops of Cav1.1 are necessary to restore the full
extent of orthograde and retrograde signaling between Cav1.1
and RyR1 [15]. The present ﬁndings also support in vitro
results from pull-down assays, where it was demonstrated
that CaM-binding region of RyR1 (3614–3543) interacts
with the proximal C-terminus of Cav1.1 (1393–1527) in the
absenceofCaM[18,19].ItwasalsoshownthatCaMbinding
to the RyR1 is not essential for skeletal EC coupling [20].
This would indicate together with binding studies [18] that
CaM association to either Cav1.1 or RyR1 is not crucial for
skeletal muscle EC coupling, but CaM-binding domains of
both Cav1.1 and RyR1 are. For example, it has been shown
that CaM-binding region of RyR1 binds to IQ peptide of
Cav1.2 and in pull-down assay binds to Cav1.1 [18]. It still
remains to be determined whether CaM itself needs to be
tethered to Cav1.1 to ensure signaling and more experiments
are in progress.
In conclusion, the results from confocal microscopy,
immunocytochemistry, charge movement, and Ca2+ tran-
sients obtained from dysgenic myotubes expressing YFP-
Cav1.1AA indicate that the IQ motif in the C-terminus of
Cav1.1 plays a crucial role in both orthograde (EC coupling)
and retrograde (Ca2+ current) signaling between Cav1.1 and
RyR1.
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